Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for PetMed Express Inc. (PETS:NASDAQ), powered by AI.
PetMed Express Inc. is currently trading at $1.80. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for PetMed Express Inc. on Alpha Lenz.
View PetMed Express Inc.'s valuation metrics on Alpha Lenz.
PetMed Express Inc. is a leading retailer in the pet medication and health products industry. The company specializes in delivering prescription and non-prescription pet medications directly to customers, predominantly serving the pet owners' market in the United States. PetMed Express offers a variety of products for dogs, cats, and small pets, including prescription and non-prescription medications, health supplies, and nutritional supplements. Through its platform, 1-800-PetMeds, it aims to provide pet owners with a convenient, cost-effective alternative to purchasing veterinary medications. The company plays a vital role in the burgeoning pet care industry, which continues to grow as pet ownership becomes more prevalent. Founded in 1996 and headquartered in Florida, PetMed Express frequently emphasizes the importance of accessibility to high-quality pet care products. Its business model combines e-commerce and personalized customer service, positioning itself as a key player in meeting the demands of pet health care in modern lifestyles.
PetMed Express Inc. (ticker: PETS) is a company listed on NASDAQ in the Healthcare sector (Pharmaceutical Retailers). It has approximately 287 employees. Market cap is $37M.
The current price is $1.8 with a P/E ratio of -x and P/B of -x.